Austin Health

Title
'Massive' metformin overdose.
Publication Date
2018-12
Author(s)
Chiew, Angela L
Wright, Daniel F B
Dobos, Nicola M
McArdle, Kylie
Mostafa, Ahmed A
Newth, Annemarie
Roberts, Michael S
Isbister, Geoffrey K
Subject
extracorporeal elimination
metabolic acidosis
metformin
overdose
Type of document
Journal Article
OrcId
0000-0002-0079-5056
0000-0001-9313-9252
0000-0003-1519-7419
DOI
10.1111/bcp.13582
Abstract
Massive metformin overdose can cause metabolic acidosis with hyperlactatemia. A 55-year-old woman presented 5 h after multidrug overdose, including 132 g extended-release metformin. Continuous venovenous haemodiafiltration (CVVHDF) and noradrenaline were commenced due to metabolic acidosis (pH 7.0, lactate 17 mmol l-1 ) and shock. Despite 3 h of CVVHDF, her acidosis worsened (pH 6.83, lactate 24 mmol l-1 ). Intermittent haemodialysis (IHD) improved acidosis (pH 7.13, lactate 26 mmol l-1 ) but again worsened (pH 6.91, lactate 30 mmol l-1 ) with CVVHDF recommencement. IHD (12 h), CVVHDF (26 h) and vasopressor support for 7 days resulted in survival. Measured metformin concentrations were extremely high with a peak of 292 μg ml-1 at 8 h postingestion. IHD, but not CVVHDF in this case, was associated with improvement in metabolic acidosis and hyperlactataemia. Pharmacokinetic analysis of metformin concentrations found a reduced apparent oral clearance of 8.2 l h-1 and a half-life of approximately 30 h. During IHD, the apparent oral clearance increased to 22.2 l h-1 with an approximate half-life of 10 h. The impact of prolonged oral absorption from a pharmacobezoar and redistribution of metformin from peripheral sites (including erythrocytes) on the pharmacokinetic profile cannot be determined from the data available.
Link
Citation
British journal of clinical pharmacology 2018; 84(12): 2923-2927
Jornal Title
British journal of clinical pharmacology

Files:

NameSizeformatDescriptionLink